Aortic dissection other diagnostic studies

Jump to: navigation, search

Aortic dissection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic dissection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Special Scenarios

Management during Pregnancy

Case Studies

Case #1

Aortic dissection other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic dissection other diagnostic studies

CDC on Aortic dissection other diagnostic studies

Aortic dissection other diagnostic studies in the news

Blogs on Aortic dissection other diagnostic studies

Directions to Hospitals Treating Aortic dissection other diagnostic studies

Risk calculators and risk factors for Aortic dissection other diagnostic studies

Overview

Other Diagnostic Studies

2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases (DO NOT EDIT)[1]

Genetic Testing in Aortic Dissection (DO NOT EDIT)[1]

Class I
"It is recommended to investigate first-degree relatives (siblings and parents) of a subject with TAAD to identify a familial form in which relatives all have a 50% chance of carrying the family mutation/disease.(Level of Evidence: B)"
"Once a familial form of TAAD is highly suspected, it is recommended to refer the patient to a geneticist for family investigation and molecular testing.(Level of Evidence: C)"
"Variability of age of onset warrants screening every 5 years of ‘healthy’ at-risk relatives until diagnosis (clinical or molecular) is established or ruled out.(Level of Evidence: C)"
Class IIa
"In familial non-syndromic TAAD, screening for aneurysm should be considered, not only in the thoracic aorta, but also throughout the arterial tree (including cerebral arteries).(Level of Evidence: C)"

References

  1. 1.0 1.1 Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ (November 2014). "2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)". Eur. Heart J. 35 (41): 2873–926. doi:10.1093/eurheartj/ehu281. PMID 25173340.


Cardiology


Linked-in.jpg